59
Views
4
CrossRef citations to date
0
Altmetric
Review

Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann’s thrombasthenia

Pages 655-664 | Published online: 28 Dec 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Natalie Mathews, Georges-Etienne Rivard & Arnaud Bonnefoy. (2021) Glanzmann Thrombasthenia: Perspectives from Clinical Practice on Accurate Diagnosis and Optimal Treatment Strategies. Journal of Blood Medicine 12, pages 449-463.
Read now
John Puetz. (2014) Overview of the use of recombinant factor VIIa in children. Pediatric Health, Medicine and Therapeutics 5, pages 141-148.
Read now
Boris Shenkman, Tami Livnat, Mudi Misgav, Ivan Budnik, Yulia Einav & Uriel Martinowitz. (2012) The in vivo effect of fibrinogen and factor XIII on clot formation and fibrinolysis in Glanzmann's thrombasthenia. Platelets 23:8, pages 604-610.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.